Oncoustics AI
Miriam Naim Ibrahim serves as the Clinical & Data Operations Manager and Clinical Data Scientist at Oncoustics since May 2019, while also holding the position of Researcher at the University Health Network since May 2021. Prior experience includes a role in Manufacturing Development at The Coca-Cola Company from January to October 2018, a Research Assistant position at the University of Guelph during the summer of 2017, and work as a Dental Assistant at Dr. Alfred A. Wannas Dental Office from April 2016 to August 2017. Miriam Naim Ibrahim holds a Master of Applied Science in Engineering with a focus on AI and Medical Imaging and a Bachelor of Engineering in Biomedical Engineering, both from the University of Guelph.
Oncoustics AI
Oncoustics is creating and deploying advanced AI solutions for low cost, non-invasive surveillance, diagnostics, and treatment monitoring of diseases with high unmet clinical need. Unlike other players in the space, Oncoustics does not do image recognition. Instead, Oncoustics applies AI to raw ultrasound signals from readily available handheldultrasound devices to rapidly differentiate healthy versus diseased tissues. There's a wealth of information in these raw signals and this approach reveals novel biomarkers that can be aligned with existing standards and categorization systems. Initially targeting liver disease, a $30B global diagnostic market, Oncoustics has filed a Breakthrough Device Designation Request with the FDA for the OnX that detects liver fibrosis and the 510K is underway. Several follow-on liver products are in development. Oncoustics also has clinical data on other organ indications including prostate, kidney, breast and thyroid diseases and cancers.